The effect of sacubitril/valsartan compared to olmesartan on cardiovascular remodelling in subjects with essential hypertension: the results of a randomized, double-blind, active-controlled study.

Roland E Schmieder; Frank Wagner; Michael Mayr; Christian Delles; Christian Ott; Christian Keicher; Maja Hrabak-Paar; Tobias Heye; Solveig Aichner; Yasser Khder; Denise Yates; Diego Albrecht; Thomas Langenickel; Patrick Freyhardt; Rolf Janka; Jens Bremerich

doi:10.1093/eurheartj/ehx525

The effect of sacubitril/valsartan compared to olmesartan on cardiovascular remodelling in subjects with essential hypertension: the results of a randomized, double-blind, active-controlled study.

Roland E Schmieder, Frank Wagner, Michael Mayr, Christian Delles, Christian Ott, Christian Keicher, Maja Hrabak-Paar, Tobias Heye, Solveig Aichner, Yasser Khder, Denise Yates, Diego Albrecht, Thomas Langenickel, Patrick Freyhardt, Rolf Janka, Jens Bremerich

Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung

121 Quellenangaben (Web of Science)

Originalsprache	Englisch
Seiten (von - bis)	3308-3317
Fachzeitschrift	EUROPEAN HEART JOURNAL
Jahrgang	38
Ausgabenummer	44
DOIs	https://doi.org/10.1093/eurheartj/ehx525
Publikationsstatus	Veröffentlicht - 2017

Zugriff auf Dokument

10.1093/eurheartj/ehx525

Dieses zitieren

Schmieder, R. E., Wagner, F., Mayr, M., Delles, C., Ott, C., Keicher, C., Hrabak-Paar, M., Heye, T., Aichner, S., Khder, Y., Yates, D., Albrecht, D., Langenickel, T., Freyhardt, P., Janka, R., & Bremerich, J. (2017). The effect of sacubitril/valsartan compared to olmesartan on cardiovascular remodelling in subjects with essential hypertension: the results of a randomized, double-blind, active-controlled study. EUROPEAN HEART JOURNAL , 38(44), 3308-3317. https://doi.org/10.1093/eurheartj/ehx525

Schmieder, Roland E ; Wagner, Frank ; Mayr, Michael et al. / The effect of sacubitril/valsartan compared to olmesartan on cardiovascular remodelling in subjects with essential hypertension: the results of a randomized, double-blind, active-controlled study. in: EUROPEAN HEART JOURNAL 2017 ; Jahrgang 38, Nr. 44. S. 3308-3317.

@article{434f4f60a1294c7fa52209872487af07,

title = "The effect of sacubitril/valsartan compared to olmesartan on cardiovascular remodelling in subjects with essential hypertension: the results of a randomized, double-blind, active-controlled study.",

keywords = "LEFT-VENTRICULAR MASS, ANGIOTENSIN-CONVERTING ENZYME, NEUTRAL ENDOPEPTIDASE INHIBITOR, AORTIC STIFFNESS, SYSTOLIC HYPERTENSION, NEPRILYSIN INHIBITOR, ARTERIAL STIFFNESS, PULSE PRESSURE, HEART-FAILURE, II RECEPTOR",

author = "Schmieder, {Roland E} and Frank Wagner and Michael Mayr and Christian Delles and Christian Ott and Christian Keicher and Maja Hrabak-Paar and Tobias Heye and Solveig Aichner and Yasser Khder and Denise Yates and Diego Albrecht and Thomas Langenickel and Patrick Freyhardt and Rolf Janka and Jens Bremerich",

year = "2017",

doi = "10.1093/eurheartj/ehx525",

language = "English",

volume = "38",

pages = "3308--3317",

journal = "EUROPEAN HEART JOURNAL ",

issn = "0195-668X",

publisher = "Oxford Univ Press",

number = "44",

}

Schmieder, RE, Wagner, F, Mayr, M, Delles, C, Ott, C, Keicher, C, Hrabak-Paar, M, Heye, T, Aichner, S, Khder, Y, Yates, D, Albrecht, D, Langenickel, T, Freyhardt, P, Janka, R & Bremerich, J 2017, 'The effect of sacubitril/valsartan compared to olmesartan on cardiovascular remodelling in subjects with essential hypertension: the results of a randomized, double-blind, active-controlled study.', EUROPEAN HEART JOURNAL , Jg. 38, Nr. 44, S. 3308-3317. https://doi.org/10.1093/eurheartj/ehx525

The effect of sacubitril/valsartan compared to olmesartan on cardiovascular remodelling in subjects with essential hypertension: the results of a randomized, double-blind, active-controlled study. / Schmieder, Roland E; Wagner, Frank; Mayr, Michael et al.
in: EUROPEAN HEART JOURNAL , Jahrgang 38, Nr. 44, 2017, S. 3308-3317.

Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung

TY - JOUR

T1 - The effect of sacubitril/valsartan compared to olmesartan on cardiovascular remodelling in subjects with essential hypertension: the results of a randomized, double-blind, active-controlled study.

AU - Schmieder, Roland E

AU - Wagner, Frank

AU - Mayr, Michael

AU - Delles, Christian

AU - Ott, Christian

AU - Keicher, Christian

AU - Hrabak-Paar, Maja

AU - Heye, Tobias

AU - Aichner, Solveig

AU - Khder, Yasser

AU - Yates, Denise

AU - Albrecht, Diego

AU - Langenickel, Thomas

AU - Freyhardt, Patrick

AU - Janka, Rolf

AU - Bremerich, Jens

PY - 2017

Y1 - 2017

KW - LEFT-VENTRICULAR MASS

KW - ANGIOTENSIN-CONVERTING ENZYME

KW - NEUTRAL ENDOPEPTIDASE INHIBITOR

KW - AORTIC STIFFNESS

KW - SYSTOLIC HYPERTENSION

KW - NEPRILYSIN INHIBITOR

KW - ARTERIAL STIFFNESS

KW - PULSE PRESSURE

KW - HEART-FAILURE

KW - II RECEPTOR

U2 - 10.1093/eurheartj/ehx525

DO - 10.1093/eurheartj/ehx525

M3 - Original Article

C2 - 29029087

SN - 0195-668X

VL - 38

SP - 3308

EP - 3317

JO - EUROPEAN HEART JOURNAL

JF - EUROPEAN HEART JOURNAL

IS - 44

ER -

Schmieder RE, Wagner F, Mayr M, Delles C, Ott C, Keicher C et al. The effect of sacubitril/valsartan compared to olmesartan on cardiovascular remodelling in subjects with essential hypertension: the results of a randomized, double-blind, active-controlled study. EUROPEAN HEART JOURNAL . 2017;38(44):3308-3317. doi: 10.1093/eurheartj/ehx525